Skip to main content

Articles

Page 32 of 76

  1. MKK3 is a member of the dual specificity kinase group specific upstream activator of p38 MAPK proteins. We originally identified MKK3 as mutant p53 (mutp53) gain-of-function (GOF) upregulated target gene in di...

    Authors: Lorenzo Stramucci and Gianluca Bossi
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:504
    Content type: Commentary Published on:

  2. The treatment of metastatic osteosarcoma (OS) remains a challenge for oncologists, and novel therapeutic strategies are urgently needed. An understanding of the pathways that regulate OS dissemination is requi...

    Authors: Cinzia Zucchini, Maria Cristina Manara, Camilla Cristalli, Marianna Carrabotta, Sara Greco, Rosa Simona Pinca, Cristina Ferrari, Lorena Landuzzi, Michela Pasello, Pier-Luigi Lollini, Marco Gambarotti, Davide Maria Donati and Katia Scotlandi
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:503
    Content type: Research Published on:

  3. Gastric cancer (GC) is one of the most prevalent and deadly malignancies worldwide. Accumulating reports have indicated the participation of long non-coding RNAs (lncRNAs) in the onset and progression of GC.

    Authors: Yangyang Dong, Xinyu Li, Zhibin Lin, Wenbing Zou, Yan Liu, Huiyang Qian and Jing Jia
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:502
    Content type: Research Published on:

  4. Esophageal cancer is one of the most common malignant tumors in the world. With currently available therapies, only 20% ~ 30% patients can survive this disease for more than 5 years. TRAIL, a natural ligand fo...

    Authors: Lujuan Han, Suli Dai, Zhirong Li, Cong Zhang, Sisi Wei, Ruinian Zhao, Hongtao Zhang, Lianmei Zhao and Baoen Shan
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:501
    Content type: Research Published on:

  5. In the original publication of this article [1], the author found an error in Fig. 2f. lncGPR107 should be changed to lncMAPK6, and the corrected Fig. 2 is shown below.

    Authors: Guanqun Huang, Hui Jiang, Yueming He, Ye Lin, Wuzheng Xia, Yuanwei Luo, Min Liang, Boyun Shi, Xinke Zhou and Zhixiang Jian
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:500
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2018 37:105

  6. Mortalin is enriched in a large variety of cancers and has been shown to contribute to proliferation and migration of cancer cells in multiple ways. It has been shown to bind to p53 protein in cell cytoplasm a...

    Authors: Jayarani F. Putri, Priyanshu Bhargava, Jaspreet Kaur Dhanjal, Tomoko Yaguchi, Durai Sundar, Sunil C. Kaul and Renu Wadhwa
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:499
    Content type: Research Published on:

  7. The MYCN amplification is a defining hallmark of high-risk neuroblastoma. Due to irregular oncogenes orchestration, tumor cells exhibit distinct fatty acid metabolic features from non-tumor cells. However, the...

    Authors: Yi Ding, Jie Yang, Yawen Ma, Tengteng Yao, Xingyu Chen, Shengfang Ge, Lihua Wang and Xianqun Fan
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:498
    Content type: Research Published on:

  8. The survival of pancreatic cancer patients remains poor. However, the underlying molecular mechanism and new therapeutic target of pancreatic cancer are still needed to be found. Many studies have shown that t...

    Authors: Xiaodong Xu, Yan Yu, Ke Zong, Pengwei Lv and Yuantin Gu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:497
    Content type: Research Published on:

  9. In the original publication of this article [1], the images of Figs. 4 and 5 were exchanged and the legends of the two figures did not correspond due to a typesetting error.

    Authors: Mineko Terao, Laura Goracci, Valentina Celestini, Mami Kurosaki, Marco Bolis, Alessandra Di Veroli, Arianna Vallerga, Maddalena Fratelli, Monica Lupi, Alessandro Corbelli, Fabio Fiordaliso, Maurizio Gianni, Gabriela Paroni, Adriana Zanetti, Gabriele Cruciani and Enrico Garattini
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:496
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:436

  10. Human bone marrow mesenchymal stem cells (hBMSCs) are implicated in cancer initiation and metastasis, sometimes by releasing exosomes that mediate cell communication by delivering microRNAs (miRNAs). This stud...

    Authors: Shuangjian Jiang, Chengqiang Mo, Shengjie Guo, Jintao Zhuang, Bin Huang and Xiaopeng Mao
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:495
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2022 41:206

  11. Downregulation of microRNA-338-3p (miR-338-3p) was detected in many malignant tumors, which indicated miR-338-3p might serve as a role of antioncogene in those cancers. The present study aimed to explore the r...

    Authors: Ruitao Zhang, Huirong Shi, Fang Ren, Wei Feng, Yuan Cao, Gailing Li, Zheying Liu, Pengcheng Ji and Minghui Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:494
    Content type: Research Published on:

  13. Molecular mechanisms driving acquired resistance to anti-EGFR therapies in metastatic colorectal cancer (mCRC) are complex but generally involve the activation of the downstream RAS-RAF-MEK-MAPK pathway. Never...

    Authors: S. Napolitano, N. Matrone, A. L. Muddassir, G. Martini, A. Sorokin, V. De Falco, E. F. Giunta, D. Ciardiello, E. Martinelli, V. Belli, M. Furia, S. Kopetz, F. Morgillo, F. Ciardiello and T. Troiani
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:492
    Content type: Research Published on:

  14. Growing evidence showed the increased prevalence of cancer incidents, particularly colorectal cancer, among type 2 diabetic mellitus patients. Antidiabetic medications such as, insulin, sulfonylureas, dipeptyl...

    Authors: Muhamad Noor Alfarizal Kamarudin, Md. Moklesur Rahman Sarker, Jin-Rong Zhou and Ishwar Parhar
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:491
    Content type: Review Published on:

  15. N-myc downstream-regulated gene 1 (NDRG1) has been shown to play a key role in tumor metastasis. Recent studies demonstrate that NDRG1 can suppress tumor growth and is related to tumor proliferation; however, ...

    Authors: Sen Zhang, Chaoran Yu, Xiao Yang, Hiju Hong, Jiaoyang Lu, Wenjun Hu, Xiaohui Hao, Shuchun Li, Batuer Aikemu, Guang Yang, Zirui He, Luyang Zhang, Pei Xue, Zhenghao Cai, Junjun Ma, Lu Zang…
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:490
    Content type: Research Published on:

  16. Ischemia reperfusion injury (IRI) has been shown to increase the risk of tumor recurrence after liver surgery. Also, nonalcoholic fatty liver disease (NAFLD) is associated with increased HCC recurrence. ALOX12...

    Authors: Faji Yang, Yuheng Zhang, Haozhen Ren, Jinglin Wang, Longcheng Shang, Yang Liu, Wei Zhu and Xiaolei Shi
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:489
    Content type: Research Published on:

  17. Accumulating evidence indicates that aberrant microRNA (miRNA) expression contributes to osteosarcoma progression. This study aimed to elucidate the association between miR-624-5p expression and osteosarcoma (...

    Authors: Yongjun Luo, Wei Liu, Pengyu Tang, Dongdong Jiang, Changjiang Gu, Yumin Huang, Fangyi Gong, Yuluo Rong, Dingfei Qian, Jian Chen, Zheng Zhou, Shujie Zhao, Jiaxing Wang, Tao Xu, Yongzhong Wei, Guoyong Yin…
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:488
    Content type: Research Published on:

  18. Arsenic sulfide was found to have potential anti-cancer activities, especially in gastric cancer. However, the underlying mechanism need to be further explored. This study was aimed to investigate the mechanis...

    Authors: Ting Kang, Maolin Ge, Ruiheng Wang, Zhen Tan, Xiuli Zhang, Chuanying Zhu, Han Liu and Siyu Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:487
    Content type: Research Published on:

  19. Gliomas are common life-threatening cancers, mainly due to their aggressive nature and frequent invasiveness and long non-coding RNAs (lncRNAs) are emerging as promising molecular targets. Therefore, we explor...

    Authors: Haiyang Xu, Guifang Zhao, Yu Zhang, Hong Jiang, Weiyao Wang, Donghai Zhao, Hongquan Yu and Ling Qi
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:486
    Content type: Research Published on:

  20. Recent studies have reported that Integrin alpha 2 (ITGA2) plays an essential role in tumor cell proliferation, invasion, metastasis, and angiogenesis. An abnormally expressed ITGA2 correlates with unfavorable...

    Authors: Dianyun Ren, Jingyuan Zhao, Yan Sun, Dan Li, Zibo Meng, Bo Wang, Ping Fan, Zhiqiang Liu, Xin Jin and Heshui Wu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:485
    Content type: Research Published on:

  21. Protein tyrosine phosphatase receptor delta (PTPRD) is frequently inactivated in various types of cancers. Here, we explored the underlying mechanism of PTPRD-loss-induced cancer metastasis and investigated an...

    Authors: Won Jung Bae, Ji Mi Ahn, Hye Eun Byeon, Seokwhi Kim and Dakeun Lee
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:484
    Content type: Research Published on:

  22. The dysfunction of type I interferon (IFN) signaling is an important mechanism of immune escape and metastasis in tumors. Increased NOS1 expression has been detected in melanoma, which correlated with dysfunct...

    Authors: Pengfei Xu, Shuangyan Ye, Keyi Li, Mengqiu Huang, Qianli Wang, Sisi Zeng, Xi Chen, Wenwen Gao, Jianping Chen, Qianbing Zhang, Zhuo Zhong, Ying Lin, Zhili Rong, Yang Xu, Bingtao Hao, Anghui Peng…
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:483
    Content type: Research Published on:

  23. Identification of novel cancer-associated splice variants is of potential diagnostic, prognostic and therapeutic importance. NF-Y transcription factor is comprised of NF-YA, NF-YB and NF-YC subunits, binds inv...

    Authors: Lucia Cappabianca, Antonietta Rosella Farina, Lucia Di Marcotullio, Paola Infante, Daniele De Simone, Michela Sebastiano and Andrew Reay Mackay
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:482
    Content type: Research Published on:

  24. Although EGFR tyrosine kinase inhibitors (EGFR-TKIs) are beneficial to lung adenocarcinoma patients with sensitive EGFR mutations, resistance to these inhibitors induces a cancer stem cell (CSC) phenotype. Her...

    Authors: Jiahui Si, Yuanyuan Ma, Ji Wang Bi, Ying Xiong, Chao Lv, Shaolei Li, Nan Wu and Yue Yang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:481
    Content type: Research Published on:

  25. In the original publication of this article [1], Fig. 6 is wrong and the updated figure is shown below.

    Authors: Xiao-Ping Chen, Xin Long, Wen-long Jia, Han-Jie Wu, Jing Zhao, Hui-Fang Liang, Arian Laurence, Jun Zhu, Dong Dong, Yan Chen, Long Lin, Yu-Dong Xia, Wei-Yang Li, Gui-Bo Li, Zhi-Kun Zhao, Kui Wu…
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:480
    Content type: Correction Published on:

    The original article was published in Journal of Experimental & Clinical Cancer Research 2019 38:261

  26. Non small cell lung cancer (NSCLC) is one of the most common cancers in the world. DHA is known to be capable of suppressing NSCLC cell proliferation and metastasis. However, the mechanisms by which DHA exhibi...

    Authors: Xiaoming Bai, Jiaofang Shao, Sujin Zhou, Zhenggang Zhao, Fanghong Li, Rong Xiang, Allan Z. Zhao and Jinshun Pan
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:479
    Content type: Research Published on:

  27. KH-type splicing regulatory protein (KHSRP) plays an important role in cancer invasion, but the relevant mechanism is not well known. In the present study, we investigated the function and potential molecular ...

    Authors: Mingxia Yan, Lei Sun, Jing Li, Huajian Yu, Hechun Lin, Tao Yu, Fangyu Zhao, Miaoxin Zhu, Lei Liu, Qin Geng, Hanwei Kong, Hongyu Pan and Ming Yao
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:478
    Content type: Research Published on:

  28. In recent years, long non-coding RNAs (lncRNAs) are of great importance in development of different types of tumors, while the function of lncRNA ZFAS1 is rarely discussed in esophageal squamous cell carcinoma...

    Authors: Zhirong Li, Xuebo Qin, Wei Bian, Yishuai Li, Baoen Shan, Zhimeng Yao and Shujun Li
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:477
    Content type: Research Published on:

  29. Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer. The dismal outcome of ICC patients is due to lack of early diagnosis, the aggressive biological behavior of ICC and the lac...

    Authors: Jian-Hui Li, Xiao-Xu Zhu, Fu-Xi Li, Chen-Song Huang, Xi-Tai Huang, Jie-Qin Wang, Zhuo-Xing Gao, Shi-Jin Li, Qiong-Cong Xu, Wei Zhao and Xiao-Yu Yin
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:476
    Content type: Research Published on:

  30. Forkhead box G1 (FOXG1) is a member of the Fox transcription factor family involved in regulation of many cancers. However, the role of FOXG1 in hepatocellular carcinogenesisis largely unclear. The present stu...

    Authors: Xingrong Zheng, Jiaxin Lin, Hewei Wu, Zhishuo Mo, Yunwen Lian, Peipei Wang, Zhaoxia Hu, Zhiliang Gao, Liang Peng and Chan Xie
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:475
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2021 40:104

  31. The inflammatory cytokine interleukin-6 (IL-6) is critical for the expression of octamer-binding transcription factor 4 (OCT4), which is highly associated with early tumor recurrence and poor prognosis of hepa...

    Authors: Ssu-Chuan Lai, Yu-Ting Su, Ching-Chi Chi, Yung-Che Kuo, Kam-Fai Lee, Yu-Chih Wu, Pei-Chi Lan, Muh-Hwa Yang, Te-Sheng Chang and Yen-Hua Huang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:474
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2020 39:10

  32. Circulating tumour cells (CTCs), especially mesenchymal CTCs, are important determinants of metastasis, which leads to most recurrence and mortality in hepatocellular carcinoma (HCC). However, little is known ...

    Authors: Yujun Tang, Yishi Lu, Yuan Chen, Lei Luo, Lei Cai, Bangjian Peng, Wenbin Huang, Hangyu Liao, Liang Zhao and Mingxin Pan
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:473
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2021 40:234

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2020 39:130

  33. Alteration of signalling pathways regulating cell cycle progression is a common feature of cancer cells. Several drugs targeting distinct phases of the cell cycle have been developed but the inability of many ...

    Authors: Ouma Cisse, Muzthahid Quraishi, Federico Gulluni, Federica Guffanti, Ioanna Mavrommati, Methushaa Suthanthirakumaran, Lara C. R. Oh, Jessica N. Schlatter, Ambisha Sarvananthan, Massimo Broggini, Emilio Hirsch, Marco Falasca and Tania Maffucci
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:472
    Content type: Research Published on:

  34. Adhesion molecules distributed on the cell-surface depends upon their dynamic trafficking that plays an important role during cancer progression. ADP-ribosylation factor 6 (Arf6) is a master regulator of membr...

    Authors: Shanshan Qi, Linjia Su, Jing Li, Chuanshan Zhang, Zhe Ma, Guiqiu Liu, Qing Zhang, Guhe Jia, Yongjun Piao and Sihe Zhang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:471
    Content type: Research Published on:

  35. Accumulation evidence indicates the vital role of long non-coding RNAs (lncRNAs) in tumorigenesis and the progression of malignant tumors, including pancreatic cancer (PC). However, the role and the molecular ...

    Authors: Shan Lei, Zhiwei He, Tengxiang Chen, Xingjun Guo, Zhirui Zeng, Yiyi Shen and Jianxin Jiang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:470
    Content type: Research Published on:

  36. The activation of tumour-associated macrophages (TAMs) contributes to the progression of hepatocellular carcinoma (HCC). SIRT4 acts as a tumour suppressor of tumour growth by regulating cell metabolism, inflam...

    Authors: Zhi Li, He Li, Zhi-Bo Zhao, Wei Zhu, Pan-Pan Feng, Xi-Wen Zhu and Jian-Ping Gong
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:469
    Content type: Research Published on:

  37. The deubiquitinase USP7 has been identified as an oncogene with key roles in tumorigenesis and therapeutic resistance for a series of cancer types. Recently small molecular inhibitors have been developed to ta...

    Authors: Yuchong Peng, Youhong Liu, Yingxue Gao, Bowen Yuan, Xuli Qi, Yuxin Fu, Qianling Zhu, Tuoyu Cao, Songwei Zhang, Linglong Yin and Xiong Li
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:468
    Content type: Research Published on:

  38. The NSD family of histone lysine methyltransferases have emerged as important biomarkers that participate in a variety of malignancies. Recent evidence has indicated that somatic dysregulation of the nuclear r...

    Authors: Shuhua Zhang, Fan Zhang, Qing Chen, Chidan Wan, Jun Xiong and Jianqun Xu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:467
    Content type: Research Published on:

  39. Circular RNAs (circRNAs) have recently been shown to play important roles in different tumors. However, their detailed roles and regulatory mechanisms in pancreatic ductal adenocarcinoma (PDAC) are not well un...

    Authors: Yan Chen, Zhonghu Li, Mengyun Zhang, Bo Wang, Jiaxin Ye, Yang Zhang, Di Tang, Dandan Ma, Weidong Jin, Xiaowu Li and Shuguang Wang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:466
    Content type: Research Published on:

    The Correction to this article has been published in Journal of Experimental & Clinical Cancer Research 2021 40:137

  40. Long non-coding RNAs (lncRNAs) are tumor-associated biological molecules and have been found to be implicated in the progression of colorectal cancer (CRC). This study aims to examine the effects of lncRNA RP1...

    Authors: Li Jiang, Xu-Hai Zhao, Yin-Ling Mao, Jun-Feng Wang, Hui-Jun Zheng and Qing-Shan You
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:465
    Content type: Research Published on:

  41. Prostate cancer (PCa) is a leading cause of cancer-related death in males worldwide. Exacerbated inflammation and angiogenesis have been largely demonstrated to contribute to PCa progression. Diverse naturally...

    Authors: Denisa Baci, Antonino Bruno, Caterina Cascini, Matteo Gallazzi, Lorenzo Mortara, Fausto Sessa, Giuseppe Pelosi, Adriana Albini and Douglas M. Noonan
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:464
    Content type: Research Published on:

  42. Overexpressed PES1 promotes carcinogenesis in various types of malignant tumors. However, the biological role and clinical significance of PES1 in pancreatic cancer are still unexplored.

    Authors: Xin Jin, Rui Fang, Ping Fan, Lipeng Zeng, Bin Zhang, Xiaoming Lu and Tao Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:463
    Content type: Research Published on:

  43. We investigated the role of PD-L1 in the metabolic reprogramming of non-small cell lung cancer (NSCLC).

    Authors: Sehui Kim, Ji-Young Jang, Jaemoon Koh, Dohee Kwon, Young A. Kim, Jin Chul Paeng, Chan-Young Ock, Bhumsuk Keam, Miso Kim, Tae Min Kim, Dae Seog Heo, Doo Hyun Chung and Yoon Kyung Jeon
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:462
    Content type: Research Published on:

  44. Tumor cell repopulation after radiotherapy is a major cause for the tumor radioresistance and recurrence. This study aims to investigate the underlying mechanism of tumor repopulation after radiotherapy, with ...

    Authors: Yiwei Wang, Minghui Zhao, Sijia He, Yuntao Luo, Yucui Zhao, Jin Cheng, Yanping Gong, Jianzhu Xie, Yulan Wang, Binjie Hu, Ling Tian, Xinjian Liu, Chuanyuan Li and Qian Huang
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:461
    Content type: Research Published on:

  45. Breast cancer is the most prevalent cancer among women worldwide. WZ35, an analog of curcumin, has been demonstrated to remarkably improve the pharmacokinetic profiles in vivo compared with curcumin. WZ35 exhi...

    Authors: Lihua Wang, Canwei Wang, Zheying Tao, Liqian Zhao, Zheng Zhu, Wencan Wu, Ye He, Hong Chen, Bin Zheng, Xiangjie Huang, Yun Yu, Linjun Yang, Guang Liang, Ri Cui and Tongke Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:460
    Content type: Research Published on:

  46. The biological behavior of epithelial ovarian cancer (EOC) is unique since EOC cells metastasize early to the peritoneum. Thereby, new anti-target agents designed to block trans-coelomic dissemination of EOC c...

    Authors: Michele Minopoli, Giovanni Botti, Vincenzo Gigantino, Concetta Ragone, Sabrina Sarno, Maria Letizia Motti, Giosuè Scognamiglio, Stefano Greggi, Cono Scaffa, Maria Serena Roca, Maria Patrizia Stoppelli, Gennaro Ciliberto, Nunzia Simona Losito and Maria Vincenza Carriero
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:459
    Content type: Research Published on:

  47. Hepatocellular carcinoma (HCC) still remains a dominating medical challenge in early diagnosis and clinical therapy. Centromere protein M (CENPM) has been proved to be over-expressed in HCC tissues, but carcin...

    Authors: Yusha Xiao, Rahmathullah Mohamed Najeeb, Dong Ma, Kang Yang, Qiu Zhong and Quanyan Liu
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:458
    Content type: Research Published on:

  48. MYO1C, an actin-based motor protein, is involved in the late stages of autophagosome maturation and fusion with the lysosome. The molecular mechanism by which MYO1C regulates autophagosome-lysosome fusion rema...

    Authors: Yanhao Zhang, Xiuxing Jiang, Qin Deng, Ziyi Gao, Xiangyu Tang, Ruoqiu Fu, Jinjiao Hu, Yunong Li, Lirong Li and Ning Gao
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:457
    Content type: Research Published on:

  49. Clinically, distant metastasis after primary treatment remains a key problem in nasopharyngeal carcinoma (NPC). Thus, identification of the underlying mechanisms and development of novel therapeutic strategies...

    Authors: You Zou, Rui Yang, Mao-Ling Huang, Yong-Gang Kong, Jian-Fei Sheng, Ze-Zhang Tao, Ling Gao and Shi-Ming Chen
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:456
    Content type: Research Published on:

  50. Limited effective intervention for advanced hepatocellular carcinoma (HCC) is available. This study aimed to investigate the potential clinical utility of apatinib, a highly selective inhibitor of the vascular...

    Authors: Junbin Liao, Huilin Jin, Shaoqiang Li, Lixia Xu, Zhenwei Peng, Guangyan Wei, Jianting Long, Yu Guo, Ming Kuang, Qi Zhou and Sui Peng
    Citation: Journal of Experimental & Clinical Cancer Research 2019 38:454
    Content type: Research Published on:

Annual Journal Metrics

  • 2022 Citation Impact
    11.3 - 2-year Impact Factor
    11.5 - 5-year Impact Factor
    1.870 - SNIP (Source Normalized Impact per Paper)
    2.413 - SJR (SCImago Journal Rank)

    2023 Speed
    4 days submission to first editorial decision for all manuscripts (Median)
    100 days submission to accept (Median)

    2023 Usage 
    3,003,080 downloads
    3,022 Altmetric mentions

Journal of Experimental & Clinical Cancer Research

ISSN: 1756-9966

Contact us